Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

65.65
Delayed Data
As of Mar 23
 +0.13 / +0.20%
Today’s Change
55.06
Today|||52-Week Range
68.12
+4.84%
Year-to-Date
Galapagos Begins Cystis Fibrosis Treatment Study
Mar 22 / GuruFocus News - Paid Partner Content
3 High-Yield Investments in Healthcare
Mar 14 / MotleyFool.com - Paid Partner Content
CytomX Soars on Bristol-Myers Partnership
Mar 20 / TheStreet.com - Paid Partner Content
The 19 Best-Selling Prescription Drugs of All-Time
Mar 13 / MotleyFool.com - Paid Partner Content
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
Mar 16 / Zacks.com - Paid Partner Content
Which Biotech Is the Best Dividend Stock?
Mar 11 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data
Mar 16 / Zacks.com - Paid Partner Content
AbbVie Stock Upgraded: What You Need to Know
Mar 10 / MotleyFool.com - Paid Partner Content
Infinity (INFI) Reports Narrower-than-Expected Loss in Q4
Mar 15 / Zacks.com - Paid Partner Content
These 2 Dividend Aristocrats Are Ridiculously Cheap
Mar 10 / MotleyFool.com - Paid Partner Content
3 Stocks to Add to Your Social Security Income
Mar 15 / MotleyFool.com - Paid Partner Content